articleTop 1% cited
Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System
International Journal of Radiation Oncology*Biology*Physics · 2010 · Vol. 79(5) · pp. 1487–1495
Victor A. Levin✉(The University of Texas MD Anderson Cancer Center)Luc Bidaut(The University of Texas MD Anderson Cancer Center)Ping Hou(The University of Texas MD Anderson Cancer Center)Ashok Kumar(The University of Texas MD Anderson Cancer Center)Jeffrey S. Wefel(The University of Texas MD Anderson Cancer Center)B. Nebiyou Bekele(The University of Texas MD Anderson Cancer Center)Sujit S. Prabhu(The University of Texas MD Anderson Cancer Center)Monica Loghin(The University of Texas MD Anderson Cancer Center)Mark R. Gilbert(The University of Texas MD Anderson Cancer Center)Edward F. Jackson(The University of Texas MD Anderson Cancer Center)
Brain Metastases and TreatmentLung Cancer Research StudiesHead and Neck Cancer StudiesMedicineBevacizumabPlaceboMagnetic resonance imagingRandomized controlled trialRadiation therapyGliomaSurgeryRadiologyChemotherapy
MeSH terms
BevacizumabAdultAgedAntibodies, MonoclonalBrainBrain NeoplasmsCentral Nervous SystemDouble-Blind MethodFemaleGliomaHead and Neck NeoplasmsHumansMagnetic Resonance ImagingMaleMeningeal Neoplasms
Citations
712
FWCI
24.53
field-weighted impact
References
38
Percentile
100%
vs. same field & year
Citations per year
Cited by
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
Annals of Oncology · 2018 · 1,168 citations
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Annals of Oncology · 2016 · 2,058 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.